Sequenta Report issue

For profit
Founded: San Francisco CA United States (2008)
Status: Acquired by Adaptive Biotechnologies (2015)

Organization Overview

First Clinical Trial
2015
NCT02405078
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree